Disentangling the relative contributions of tumor cell-derived versus stromal cell-derived PDPN represents a vital direction for future research, as it would refine therapeutic strategies aimed at the PDPN pathway to more precisely overcome microenvironment-driven mechanisms. The gene discussed is PDPN; the disease is neoplasm.